CMN-16021-03583
4 vaccinations
12 coded responses
49 check-ins
11 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 640 / MO
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Moderna
- 2021-03-13
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
-
2021-03-27
Survey response — day 14, dose 1MedDRA: Injection site pruritus, Injection site rash — Feeling: GoodFree text: Rash and itching at injection shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
-
2021-04-10
Dose 2 — Moderna
- 2021-04-10
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Pyrexia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: FeverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · DiarrheaAdult check-in
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
-
2021-05-15
Survey response — day 35, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-22
-
2021-07-12
Survey response — 3 months, dose 2MedDRA: Arthralgia, Heart rate increased, Visual impairment — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Heart rate high, vision issues, joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-21
-
2021-08-31
Dose 3 — Moderna
-
2021-09-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Itching · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-08
Health check-in — day 7, dose 3Feeling: Poor · Site: Redness, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-14
Survey response — day 14, dose 3MedDRA: Fatigue, Pruritus, Skin exfoliation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: My skin is peeling on my left arm and itching. Very fatiguedMedDRA releases: 2024-11 · check-in free text available
- 2021-09-21
-
2021-09-27
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-01
-
2021-10-05
Survey response — day 35, dose 3MedDRA: Arthralgia, Fatigue, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever fatigue joint painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-12
- 2021-12-02
-
2022-03-01
Survey response — 6 months, dose 3MedDRA: Dyspnoea, Fatigue, Headache, Lung disorder, Poor peripheral circulation, Renal disorder, Skin discolouration, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Lung issues heart tachycardia kidney issues extreme fatigue headaches purple feet breathing issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-01
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-02
-
2022-03-07
Call successfulCompleted over the phone
-
2022-07-24
Dose 4 — Pfizer-BioNTech
- 2022-07-24
-
2022-07-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
-
2022-07-31
Health check-in — day 7, dose 4Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-08-07
- 2022-08-14
-
2022-08-21
Survey response — day 28, dose 4MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extreme fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-08-29
Survey response — day 35, dose 4MedDRA: Brain fog — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Brain fog getting worseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-04
Survey response — day 42, dose 4MedDRA: Eye pain, Pyrexia, Somnolence — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe eye pain unable to stay awake and feverMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Survey response — 3 months, dose 4MedDRA: Eye disorder, Visual impairment — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Continuous eye sensitivity and poor visionMedDRA releases: 2024-11 · check-in free text available
-
2023-01-22
Survey response — 6 months, dose 4MedDRA: Arthritis, Inflammation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-22
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Moderna | |
| 2 | 2021-04-10 | Moderna | |
| 3 | 2021-08-31 | Moderna | No |
| 4 | 2022-07-24 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 6 — day 14, dose 1
Symptoms: Rash and itching at injection shot
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Fever
Release 8 — day 35, dose 2
Symptoms: Cold symptoms
Release 9 — 3 months, dose 2
Symptoms: Heart rate high, vision issues, joint pain
Release 9 — day 14, dose 3
Symptoms: My skin is peeling on my left arm and itching. Very fatigued
Release 10 — day 35, dose 3
Symptoms: Fever fatigue joint pain
Release 11 — 6 months, dose 3
Symptoms: Lung issues heart tachycardia kidney issues extreme fatigue headaches purple feet breathing issues
Release 12 — day 28, dose 4
Symptoms: Extreme fatigue
Release 12 — day 35, dose 4
Symptoms: Brain fog getting worse
Release 12 — day 42, dose 4
Symptoms: Severe eye pain unable to stay awake and fever
Release 12 — 3 months, dose 4
Symptoms: Continuous eye sensitivity and poor vision
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Eye disorder | · | · | ✓ |
| SD | Eye pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Poor peripheral circulation | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Renal disorder | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SD | Skin exfoliation | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release